Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Council Of EU Supports Urgent MDR Action By European Commission

Executive Summary

At last! After an intense year of lobbying by the medtech sector decision-makers have agreed to crisis management action for the EU’s Medical Device Regulation.

You may also be interested in...



German Medtechs Say MDR Ball Is In EU’s Court, Plus DRG Changes and ESG Reactions

Marc-Pierre Möll, CEO of German medtech-industry association BVMed, is hoping for a more collaborative year in 2023 after the health ministry came out with proposals to change the DRGs system and the EU finally conceded that its unhelpful MDR timetable was riding roughshod over the wellbeing of patients.

How Legacy Devices Can Remain On Market Once Former Certificates Have Expired

Published immediately after the 9 December meeting on the MDR at the Council of the EU, a new position paper explains a way forward for devices whose former MDD and AIMDD certificates are due to expire ahead of certification under the MDR.

EMA Expert Advice Pilot Could Be ‘Vital Source Of Guidance’ For SMEs

Ten medical device manufacturers will receive scientific advice from expert panels on their product clinical development strategies under a new European Medicines Agency pilot scheme. But who will it ultimately benefit and what does the scheme entail?

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147427

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel